The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector (231152)
ARTG Name
REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector
Product name
REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
evolocumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information